Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany
R. Diel a,*, T. Schaberg b, R. Loddenkemper c, T. Welte a, A. Nienhaus d
a Department of Pneumology, Medical School Hannover (MHH), Carl-Neuberg-Str.1, 30625 Hannover, Germany
b Center of Pneumology, Deaconess Hospital Rotenburg, Rotenburg/Wu¨mme, Germany
c German Central Committee against Tuberculosis, Berlin, Germany
d Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services, Hamburg, Germany
Received 10 June 2009; accepted 10 July 2009